AIM
CMD

Acrospire Investment Management’s Cantel Medical Corporation CMD Stock Holding History

Acrospire Investment Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,177
Closed -$92K – 1741
2017
Q2 		$92K Buy
+1,177
New +$88.4K 0.09% 301
2016
Q3 		– Sell
-1,477
Closed -$102K – 2247
2016
Q2 		$102K Buy
1,477
+500
+51% +$34.5K 0.08% 436
2016
Q1 		$70K Buy
+977
New +$61.3K 0.05% 633

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Acrospire Investment Management's CMD Position: Q3 2017 in Review

Acrospire Investment Management sold out of Cantel Medical Corporation (CMD) in Q3 2017, closing a stake of 1,177 shares — an estimated $92K sold.

Acrospire Investment Management first reported a position in CMD in Q1 2016 and held it in 3 quarters. The position peaked at $102K in Q2 2016. 231 funds tracked by Wall St. Rank hold CMD as of Q3 2017.

  • Acrospire Investment Management reported no remaining Cantel Medical Corporation position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,177 Cantel Medical Corporation shares in Q3 2017, an estimated $92K.
  • Acrospire Investment Management first reported a position in Cantel Medical Corporation in Q1 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Cantel Medical Corporation position peaked at $102K in Q2 2016.
  • 231 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.